Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared

A Tale of Two Companies: Revenue Growth from 2014 to 2023

In the dynamic world of pharmaceuticals and retail, Sarepta Therapeutics, Inc. and Walgreens Boots Alliance, Inc. present a fascinating study in contrasts. Over the past decade, Sarepta Therapeutics has seen a meteoric rise in revenue, growing from a modest $10 million in 2014 to an impressive $1.24 billion by 2023. This represents a staggering increase of over 12,000%, underscoring the company's rapid expansion in the biotech sector.

Meanwhile, Walgreens Boots Alliance, a stalwart in the retail pharmacy space, has demonstrated steady growth. Starting at approximately $76 billion in 2014, its revenue climbed to nearly $139 billion by 2023, marking a solid 82% increase. This growth reflects the company's resilience and adaptability in a competitive market.

While Sarepta's data for 2024 is missing, Walgreens continues its upward trajectory, projected to reach $148 billion. This comparison highlights the diverse growth strategies and market dynamics of these two industry leaders.